SAINTE-FOY, QUEBEC -- (MARKET WIRE) -- November 27, 2006 -- Bioxel Pharma Inc. (TSX VENTURE: BIP), a leading manufacturer of taxane active pharmaceutical ingredients and developer of targeted oncology drugs, today announced its results for the third quarter ended September 30, 2006.
